| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
88 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | DGX Quest Diagnostics INC | Doherty Catherine T. | EVP, Regional Businesses | Sell | 351 | $209.10 | $73,394.94 | -0.5% | - | - | |
| Feb 12, 2026 | COSM Cosmos Health INC. | Siokas Grigorios | Chief Executive Officer | Buy | 388,532 | $0.37 | $145,000.14 | +4.6% | - | - | |
| Feb 12, 2026 | LH Labcorp Holdings INC. | Meltzer Jonathan C | EVP, Operations | Sell | 87 | $290.42 | $25,266.54 | -3.0% | - | - | |
| Feb 11, 2026 | COSM Cosmos Health INC. | Siokas Grigorios | Chief Executive Officer | Buy | 291,262 | $0.41 | $119,999.94 | +3.6% | - | - | |
| Feb 11, 2026 | LH Labcorp Holdings INC. | Schechter Adam H | President &CEO | Sell | 5,273 | $284.38 | $1,499,535.74 | -5.7% | - | - | |
| Feb 10, 2026 | ALHC Alignment Healthcare, INC. | Wagner Andreas P. | Chief Human Resources Officer | Sell | 22,238 | $20.47 | $455,211.86 | -11.6% | - | - | |
| Feb 10, 2026 | ALHC Alignment Healthcare, INC. | Kao John E | Chief Executive Officer | Sell | 180,000 | $20.49 | $3,687,354.00 | -6.4% | - | - | |
| Feb 10, 2026 | DGX Quest Diagnostics INC | Plewman Patrick | SVP For Diagnostic Services | Sell | 5,662 | $204.00 | $1,155,048.00 | -26.9% | - | - | |
| Feb 3, 2026 | HCA Hca Healthcare, INC. | Cuffe Michael S. | EVP And Chief Clinical Officer | Sell | 1,500 | $498.09 | $747,135.15 | -4.8% | - | - | |
| Jan 15, 2026 | ALHC Alignment Healthcare, INC. | Maroney Dawn Christine | President | Sell | 30,000 | $22.48 | $674,450.94 | -1.4% | - | - | |
| Jan 12, 2026 | ALHC Alignment Healthcare, INC. | Kao John E | Chief Executive Officer | Sell | 180,000 | $21.11 | $3,799,218.96 | -3.1% | - | - | |
| Jan 8, 2026 | OSCR Oscar Health, INC. | Schlosser Mario | President Of Technology &CTO | Sell | 23,038 | $17.65 | $406,620.70 | -6.2% | - | - | |
| Jan 8, 2026 | EHSI Elite Health Systems INC. | Jeereddi Prasad Anjaneya | CEO | Buy | 3,602 | $1.42 | $5,110.86 | +0.8% | - | - | |
| Jan 7, 2026 | CLOV Clover Health Investments, CORP. /de | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2,102 | $2.53 | $5,318.06 | - | - | - | |
| Jan 6, 2026 | OSCR Oscar Health, INC. | Schlosser Mario | President Of Technology &CTO | Sell | 76,962 | $17.01 | $1,309,123.62 | -18.0% | - | - | |
| Jan 6, 2026 | ALHC Alignment Healthcare, INC. | Kim Hyong | Chief Medical Officer | Sell | 16,506 | $21.35 | $352,356.88 | -4.7% | - | - | |
| Jan 6, 2026 | ALHC Alignment Healthcare, INC. | Maroney Dawn Christine | President | Sell | 328,152 | $20.94 | $6,871,050.10 | -12.3% | - | - | |
| Jan 6, 2026 | JYNT Joint CORP | Jobson Charles E | 10% Owner | Buy | 5,240 | $8.89 | $46,583.60 | +0.3% | - | - | |
| Jan 5, 2026 | MCK McKesson CORP | Rodgers Thomas L | EVP, Chief Strategy &Bdo | Sell | 276 | $816.18 | $225,265.68 | -10.8% | - | - | |
| Jan 5, 2026 | OSCR Oscar Health, INC. | Schlosser Mario | President Of Technology &CTO | Sell | 234,861 | $15.28 | $3,587,707.58 | -24.8% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.